Remove Documentation Remove Drug Development Remove Research Laboratories
article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

“Clearly the number one challenge in 2022, as mandated by the EU GMP Guidelines for the Manufacture of Sterile Medicinal Products Annex 1 1 , is the development of a Contamination Control Strategy (CCS),” Tony Cundell noted. He warned, “Implementation of a CCS will require more than writing documents.”.

Vaccines 128